3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma
10
Leukemia, Myeloid, Acute
9
Hodgkin Disease
8
Lymphoma, Non-Hodgkin
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Leukemia
6
Multiple Myeloma
5
Lymphoma, Large B-Cell, Diffuse
5
Small Cell Lung Carcinoma
4
Sarcoma
4
Recurrence
4
Neuroblastoma
4
Central Nervous System Neoplasms
4
Lymphoma, T-Cell
3
Lymphoma, B-Cell
3
Carcinoma, Non-Small-Cell Lung
3
Burkitt Lymphoma
3
Teratoma
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Osteosarcoma
2
Optic Nerve Glioma
2
Oligodendroglioma
2
Neoplasms
2
Myelodysplastic Syndromes
2
Lymphoma, Large-Cell, Anaplastic
2
Lymphoma, B-Cell, Marginal Zone
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Immunoblastic Lymphadenopathy
2
Congenital Abnormalities
2
Breast Neoplasms
2
Interventions
Temozolomide
7
Magnetic Resonance Spectroscopy
7
X-Rays
5
Phantoms, Imaging
5
Bevacizumab
5
Specimen Handling
4
Nuclear Medicine Department, Hospital
4
Carboplatin
3
Biopsy
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
olaparib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
Vemurafenib
2
Lapatinib
2
LY3023414
2
Everolimus
2
Etoposide
2
Erlotinib Hydrochloride
2
veliparib
1
pomalidomide
1
poly ICLC
1
picropodophyllin
1
marizomib
1
imetelstat
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Ependymoma
×
etoposide phosphate
×
Clear all
No trials found.